Blood test could customize breast cancer radiation, reduce side effects
NCT ID NCT06382818
Summary
This study aims to personalize radiation therapy for breast cancer patients based on their individual risk of the cancer returning and their personal likelihood of experiencing side effects. Researchers will use a blood test to predict a patient's sensitivity to radiation and group them into one of four treatment plans. The goal is to match each patient with the radiation approach that best controls their cancer while minimizing potential harm from treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Du Cancer de Montpellier
RECRUITINGMontpellier, France
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.